Disseminated intravascular coagulation (DIC) seriously ill patients.

R. Abizanda,F. X. Valle,J. Guicafre,R. Jordá,R. Claramonte

IF: 38.9

1980-11-01

Intensive Care Medicine

Abstract:

What problem does this paper attempt to address?

Interoperability of phenome-wide multimorbidity patterns: a comparative study of two large-scale EHR systems

Nick Strayer,Tess J. Vessels,Karmel W Choi,Siwei Zhang,Yajing Li,Lide Han,Brian Sharber,Ryan S Hsi,Cosmin A Bejan,Alexander G Bick,Justin M Balko,Douglas B Johnson,Lee E Wheless,Quinn S Wells,Elizabeth J Phillips,Wesley H. Self,Jill M Pulley,Consuelo H Wilkins,Qingxia Chen,Tina Hartert,Michael R Savona,Yu Shyr,Dan M Roden,Jordan W Smoller,Douglas M Ruderfer,Yaomin Xu

DOI: https://doi.org/10.1101/2024.03.28.24305045

2024-05-27

Abstract:Abstract Background: Electronic health records (EHR) are increasingly used for studying multimorbidities. However, concerns about accuracy, completeness, and EHRs being primarily designed for billing and administrative purposes raise questions about the consistency and reproducibility of EHR-based multimorbidity research. Methods: Utilizing phecodes to represent the disease phenome, we analyzed pairwise comorbidity strengths using a dual logistic regression approach and constructed multimorbidity as an undirected weighted graph. We assessed the consistency of the multimorbidity networks within and between two major EHR systems at local (nodes and edges), meso (neighboring patterns), and global (network statistics) scales. We present case studies to identify disease clusters and uncover clinically interpretable disease relationships. We provide an interactive web tool and a knowledge base combining data from multiple sources for online multimorbidity analysis. Findings: Analyzing data from 500,000 patients across Vanderbilt University Medical Center and Mass General Brigham health systems, we observed a strong correlation in disease frequencies ( Kendalls tau = 0.643) and comorbidity strengths (Pearson rho = 0.79). Consistent network statistics across EHRs suggest similar structures of multimorbidity networks at various scales. Comorbidity strengths and similarities of multimorbidity connection patterns align with the disease genetic correlations. Graph-theoretic analyses revealed a consistent core-periphery structure, implying efficient network clustering through threshold graph construction. Using hydronephrosis as a case study, we demonstrated the networks ability to uncover clinically relevant disease relationships and provide novel insights. Interpretation: Our findings demonstrate the robustness of large-scale EHR data for studying phenome-wide multimorbidities. The alignment of multimorbidity patterns with genetic data suggests the potential utility for uncovering shared biology of diseases. The consistent core-periphery structure offers analytical insights to discover complex disease interactions. This work also sets the stage for advanced disease modeling, with implications for precision medicine. Funding: VUMC Biostatistics Development Award, the National Institutes of Health, and the VA CSRD
High-throughput multimodal automated phenotyping (MAP) with application to PheWAS

Katherine P Liao,Jiehuan Sun,Tianrun A Cai,Nicholas Link,Chuan Hong,Jie Huang,Jennifer E Huffman,Jessica Gronsbell,Yichi Zhang,Yuk-Lam Ho,Victor Castro,Vivian Gainer,Shawn N Murphy,Christopher J O'Donnell,J Michael Gaziano,Kelly Cho,Peter Szolovits,Isaac S Kohane,Sheng Yu,Tianxi Cai

DOI: https://doi.org/10.1093/jamia/ocz066

2019-11-01

Abstract:Objective: Electronic health records linked with biorepositories are a powerful platform for translational studies. A major bottleneck exists in the ability to phenotype patients accurately and efficiently. The objective of this study was to develop an automated high-throughput phenotyping method integrating International Classification of Diseases (ICD) codes and narrative data extracted using natural language processing (NLP). Materials and methods: We developed a mapping method for automatically identifying relevant ICD and NLP concepts for a specific phenotype leveraging the Unified Medical Language System. Along with health care utilization, aggregated ICD and NLP counts were jointly analyzed by fitting an ensemble of latent mixture models. The multimodal automated phenotyping (MAP) algorithm yields a predicted probability of phenotype for each patient and a threshold for classifying participants with phenotype yes/no. The algorithm was validated using labeled data for 16 phenotypes from a biorepository and further tested in an independent cohort phenome-wide association studies (PheWAS) for 2 single nucleotide polymorphisms with known associations. Results: The MAP algorithm achieved higher or similar AUC and F-scores compared to the ICD code across all 16 phenotypes. The features assembled via the automated approach had comparable accuracy to those assembled via manual curation (AUCMAP 0.943, AUCmanual 0.941). The PheWAS results suggest that the MAP approach detected previously validated associations with higher power when compared to the standard PheWAS method based on ICD codes. Conclusion: The MAP approach increased the accuracy of phenotype definition while maintaining scalability, thereby facilitating use in studies requiring large-scale phenotyping, such as PheWAS.
Design and Validation of a FHIR-based EHR-driven Phenotyping Toolbox

Pascal S. Brandt,Jennifer A. Pacheco,Prakash Adekkanattu,Evan T. Sholle,Sajjad Abedian,Daniel J. Stone,David M. Knaack,Jie Xu,Zhenxing Xu,Yifan Peng,Natalie C. Benda,Fei Wang,Yuan Luo,Guoqian Jiang,Jyotishman Pathak,Luke Rasmussen

DOI: https://doi.org/10.1093/jamia/ocac063

2022-01-01

Journal of the American Medical Informatics Association

Abstract:OBJECTIVES To develop and validate a standards-based phenotyping tool to author electronic health record (EHR)-based phenotype definitions and demonstrate execution of the definitions against heterogeneous clinical research data platforms. MATERIALS AND METHODS We developed an open-source, standards-compliant phenotyping tool known as the PhEMA Workbench that enables a phenotype representation using the Fast Healthcare Interoperability Resources (FHIR) and Clinical Quality Language (CQL) standards. We then demonstrated how this tool can be used to conduct EHR-based phenotyping, including phenotype authoring, execution, and validation. We validated the performance of the tool by executing a thrombotic event phenotype definition at 3 sites, Mayo Clinic (MC), Northwestern Medicine (NM), and Weill Cornell Medicine (WCM), and used manual review to determine precision and recall. RESULTS An initial version of the PhEMA Workbench has been released, which supports phenotype authoring, execution, and publishing to a shared phenotype definition repository. The resulting thrombotic event phenotype definition consisted of 11 CQL statements, and 24 value sets containing a total of 834 codes. Technical validation showed satisfactory performance (both NM and MC had 100% precision and recall and WCM had a precision of 95% and a recall of 84%). CONCLUSIONS We demonstrate that the PhEMA Workbench can facilitate EHR-driven phenotype definition, execution, and phenotype sharing in heterogeneous clinical research data environments. A phenotype definition that integrates with existing standards-compliant systems, and the use of a formal representation facilitates automation and can decrease potential for human error.
A framework for employing longitudinally collected multicenter electronic health records to stratify heterogeneous patient populations on disease history

Marc P Maurits,Ilya Korsunsky,Soumya Raychaudhuri,Shawn N Murphy,Jordan W Smoller,Scott T Weiss,Thomas W J Huizinga,Marcel J T Reinders,Elizabeth W Karlson,Erik B van den Akker,Rachel Knevel

DOI: https://doi.org/10.1093/jamia/ocac008

2022-04-13

Abstract:Objective: To facilitate patient disease subset and risk factor identification by constructing a pipeline which is generalizable, provides easily interpretable results, and allows replication by overcoming electronic health records (EHRs) batch effects. Material and methods: We used 1872 billing codes in EHRs of 102 880 patients from 12 healthcare systems. Using tools borrowed from single-cell omics, we mitigated center-specific batch effects and performed clustering to identify patients with highly similar medical history patterns across the various centers. Our visualization method (PheSpec) depicts the phenotypic profile of clusters, applies a novel filtering of noninformative codes (Ranked Scope Pervasion), and indicates the most distinguishing features. Results: We observed 114 clinically meaningful profiles, for example, linking prostate hyperplasia with cancer and diabetes with cardiovascular problems and grouping pediatric developmental disorders. Our framework identified disease subsets, exemplified by 6 "other headache" clusters, where phenotypic profiles suggested different underlying mechanisms: migraine, convulsion, injury, eye problems, joint pain, and pituitary gland disorders. Phenotypic patterns replicated well, with high correlations of ≥0.75 to an average of 6 (2-8) of the 12 different cohorts, demonstrating the consistency with which our method discovers disease history profiles. Discussion: Costly clinical research ventures should be based on solid hypotheses. We repurpose methods from single-cell omics to build these hypotheses from observational EHR data, distilling useful information from complex data. Conclusion: We establish a generalizable pipeline for the identification and replication of clinically meaningful (sub)phenotypes from widely available high-dimensional billing codes. This approach overcomes datatype problems and produces comprehensive visualizations of validation-ready phenotypes.
Computable Phenotypes (Cps) For Identifying Individuals With Multi-Morbidity From Real-World Data (Rwd): A Systematic Literature Review

Alipour G. Haris,P. Li,J. Bian,Y. Guo,H. Shao

DOI: https://doi.org/10.1016/j.jval.2021.04.737

IF: 5.156

2021-01-01

Value in Health

Abstract:Multimorbidity, defined as the co-occurrence of multiple chronic conditions, has posed significant health and economic burden on public health. There was an urgent need to study multimorbidity based on existing data. This study aimed to summarize CPs for multimorbidity for three mainstream data sources (survey data, administrative claims data, and electronic health records(EHRs)) through a systematic literature review. We have conducted a systemic literature review in Medline (via PubMed), Embase, and web of science. Observational studies on multimorbidity-related issues published between January 1, 2000, and December 31, 2019 were included. 2 reviewers conducted the review separately, and disagreements were resolved by the study team as whole. Fifty-two articles were included for data extraction. Eighteen studies focused on disease-specific multimorbidity, such as HIV-related multimorbidity (4), cancer-related multimorbidity (4), diabetes-related multimorbidity (3). Among them, 10 of the studies’ population was located in the USA. 13 studies used claims data, 14 studies used electronic health records, 13 studies used survey data, and the rest used different registry administrative datasets. We have summarized CPs for survey data, claims data, and EHRs, respectively. CPs we have summarized can serve as a useful instrument to support future studies on multimorbidity-related issues.
PheW2P2V: a phenome-wide prediction framework with weighted patient representations using electronic health records

Jia Guo,Krzysztof Kiryluk,Shuang Wang

DOI: https://doi.org/10.1093/jamiaopen/ooae084

2024-09-14

JAMIA Open

Abstract:Objective: Electronic health records (EHRs) provide opportunities for the development of computable predictive tools. Conventional machine learning methods and deep learning methods have been widely used for this task, with the approach of usually designing one tool for one clinical outcome. Here we developed PheW2P2V, a Phenome-Wide prediction framework using Weighted Patient Vectors. PheW2P2V conducts tailored predictions for phenome-wide phenotypes using numeric representations of patients' past medical records weighted based on their similarities with individual phenotypes. Materials and methods: PheW2P2V defines clinical disease phenotypes using Phecode mapping based on International Classification of Disease codes, which reduces redundancy and case-control misclassification in real-life EHR datasets. Through upweighting medical records of patients that are more relevant to a phenotype of interest in calculating patient vectors, PheW2P2V achieves tailored incidence risk prediction of a phenotype. The calculation of weighted patient vectors is computationally efficient, and the weighting mechanism ensures tailored predictions across the phenome. We evaluated prediction performance of PheW2P2V and baseline methods with simulation studies and clinical applications using the MIMIC-III database. Results: Across 942 phenome-wide predictions using the MIMIC-III database, PheW2P2V has median area under the receiver operating characteristic curve (AUC-ROC) 0.74 (baseline methods have values ≤0.72), median max F1-score 0.20 (baseline methods have values ≤0.19), and median area under the precision-recall curve (AUC-PR) 0.10 (baseline methods have values ≤0.10). Discussion: PheW2P2V can predict phenotypes efficiently by using medical concept embeddings and upweighting relevant past medical histories. By leveraging both labeled and unlabeled data, PheW2P2V reduces overfitting and improves predictions for rare phenotypes, making it a useful screening tool for early diagnosis of high-risk conditions, though further research is needed to assess the transferability of embeddings across different databases. Conclusions: PheW2P2V is fast, flexible, and has superior prediction performance for many clinical disease phenotypes across the phenome of the MIMIC-III database compared to that of several popular baseline methods.
How to build personalized multi-omics comorbidity profiles

Mohammad Ali Moni,Pietro Liò

DOI: https://doi.org/10.3389/fcell.2015.00028

IF: 5.5

2015-06-24

Frontiers in Cell and Developmental Biology

Abstract:Multiple diseases (acute or chronic events) occur together in a patient, which refers to the disease comorbidities, because of the multi ways associations among diseases. Due to shared genetic, molecular, environmental, and lifestyle-based risk factors, many diseases are comorbid in the same patient. Methods for integrating multiple types of omics data play an important role to identify integrative biomarkers for stratification of patients into groups with different clinical outcomes. Moreover, integrated omics and clinical information may potentially improve prediction accuracy of disease comorbidities. However, there is a lack of effective and efficient bioinformatics and statistical software for true integrative data analysis. With the availability of the wide spread huge omics, phenotype and ontology information, it is becoming more and more practical to help doctors in clinical diagnostics and comorbidity prediction by providing appropriate software tool. We developed an R software POGO to compute novel estimators of the disease comorbidity risks and patient stratification. Starting from an initial diagnosis, omics and clinical data of a patient the software identifies the association risk of disease comorbidities. The input of this software is the initial diagnosis of a patient and the output provides evidence of disease comorbidities. The functions of POGO offer flexibility for diagnostic applications to predict disease comorbidities, and can be easily integrated to high-throughput and clinical data analysis pipelines. POGO is compliant with the Bioconductor standard and it is freely available at www.cl.cam.ac.uk/~mam211/POGO/.

cell biology,developmental biology
Mergeomics: a web server for identifying pathological pathways, networks, and key regulators via multidimensional data integration

Douglas Arneson,Anindya Bhattacharya,Le Shu,Ville-Petteri Mäkinen,Xia Yang

DOI: https://doi.org/10.1186/s12864-016-3057-8

IF: 4.547

2016-09-09

BMC Genomics

Abstract:Background: Human diseases are commonly the result of multidimensional changes at molecular, cellular, and systemic levels. Recent advances in genomic technologies have enabled an outpour of omics datasets that capture these changes. However, separate analyses of these various data only provide fragmented understanding and do not capture the holistic view of disease mechanisms. To meet the urgent needs for tools that effectively integrate multiple types of omics data to derive biological insights, we have developed Mergeomics, a computational pipeline that integrates multidimensional disease association data with functional genomics and molecular networks to retrieve biological pathways, gene networks, and central regulators critical for disease development. Results: To make the Mergeomics pipeline available to a wider research community, we have implemented an online, user-friendly web server ( http://mergeomics. Research: idre.ucla.edu/ ). The web server features a modular implementation of the Mergeomics pipeline with detailed tutorials. Additionally, it provides curated genomic resources including tissue-specific expression quantitative trait loci, ENCODE functional annotations, biological pathways, and molecular networks, and offers interactive visualization of analytical results. Multiple computational tools including Marker Dependency Filtering (MDF), Marker Set Enrichment Analysis (MSEA), Meta-MSEA, and Weighted Key Driver Analysis (wKDA) can be used separately or in flexible combinations. User-defined summary-level genomic association datasets (e.g., genetic, transcriptomic, epigenomic) related to a particular disease or phenotype can be uploaded and computed real-time to yield biologically interpretable results, which can be viewed online and downloaded for later use. Conclusions: Our Mergeomics web server offers researchers flexible and user-friendly tools to facilitate integration of multidimensional data into holistic views of disease mechanisms in the form of tissue-specific key regulators, biological pathways, and gene networks.
The Phenotype Execution and Modeling Architecture ( PhEMA ) – A Standards-Based Composition of Software for Phenotype Algorithm Development

Luke V. Rasmussen,Richard C. Kiefer,Huan Mo,William K. Thompson,Guoqian Jiang,Jennifer A. Pacheco,Peter Speltz,Jie Xu,Joshua C. Denny,Enid Montague,Jyotishman Pathak

2016-01-01

Abstract:The use of a standards-based, modular architecture for the development of phenotype algorithms enhances the interoperability of electronic health record (EHR) systems to allow the dissemination of algorithms across institutions. Here we describe the implementation of previously proposed modules of a comprehensive solution for the development, validation, execution and dissemination of EHR-driven phenotype algorithms. Introduction: The use of electronic health records (EHRs) for research has been a focus of the biomedical informatics research community, with many researchers and consortia describing methodologies for effective use of EHR data, as well as challenges discovered along the way[1, 2]. To aid in the development of phenotype algorithms using clinical data, several software solutions have been provided to the informatics community, including the Informatics for Integrating Biology and the Bedside (i2b2)[3] and Observational Health Data Sciences and Informatics (OHDSI)[4]. We previously described the Phenotype Execution and Modeling Architecture (PhEMA) – a modular software architecture that relies on components that interoperate using standard formats and interfaces[5]. These components are logically separated to complete a specific task, such as executing an algorithm and collecting the results. Having referenced existing systems in development of our proposed architecture, we noted limitations and gaps that we sought to address –specifically around increasing the use of standards and providing flexibility in configuring components to meet each institution’s needs. Methods: The PhEMA development team has identified available software systems for many of the proposed seven architecture components (Library for Artifacts, Authoring, Clinical Data Repository, Execution, Validation, Data Model Services and Terminology Services) for EHR phenotyping, and developed new software in the absence of existing solutions. During development, we designed the systems around concrete interfaces and specifications, but were agnostic to the choice of a particular programming language or development environment. Results: The PhEMA solution includes one or more implemented components, as shown in Figure 1. A demonstration system and source code are available from the project website (http://projectphema.org). Briefly, each of the implemented solutions is as follows: Terminology Services – Our use of the Quality Data Model (QDM) relies on value sets (collections of terms to represent concepts, derived from standard vocabularies). We not only provide users with read access to the NLM-hosted Value Set Authority Center (VSAC) for existing value sets, but also provide a separate read/write instance of a repository for custom value sets. Both repositories leverage the Common Terminology Services 2 (CTS2) standard[6] (the VSAC CTS2 service utilizes a CTS2 wrapper [VSMC]). The authoring tool may be configured to use one or both repositories during installation. Figure 1. Implemented components of the Phenotype Execution and Modeling Architecture (PhEMA). Blue boxes indicate newly developed software, while white are existing solutions.
A global overview of genetically interpretable multimorbidities among common diseases in the UK Biobank

Guiying Dong,Jianfeng Feng,Fengzhu Sun,Jingqi Chen,Xing-Ming Zhao

DOI: https://doi.org/10.1186/s13073-021-00927-6

IF: 15.266

2021-07-05

Genome Medicine

Abstract:Abstract Background Multimorbidities greatly increase the global health burdens, but the landscapes of their genetic risks have not been systematically investigated. Methods We used the hospital inpatient data of 385,335 patients in the UK Biobank to investigate the multimorbid relations among 439 common diseases. Post-GWAS analyses were performed to identify multimorbidity shared genetic risks at the genomic loci, network, as well as overall genetic architecture levels. We conducted network decomposition for the networks of genetically interpretable multimorbidities to detect the hub diseases and the involved molecules and functions in each module. Results In total, 11,285 multimorbidities among 439 common diseases were identified, and 46% of them were genetically interpretable at the loci, network, or overall genetic architecture levels. Multimorbidities affecting the same and different physiological systems displayed different patterns of the shared genetic components, with the former more likely to share loci-level genetic components while the latter more likely to share network-level genetic components. Moreover, both the loci- and network-level genetic components shared by multimorbidities converged on cell immunity, protein metabolism, and gene silencing. Furthermore, we found that the genetically interpretable multimorbidities tend to form network modules, mediated by hub diseases and featuring physiological categories. Finally, we showcased how hub diseases mediating the multimorbidity modules could help provide useful insights for the genetic contributors of multimorbidities. Conclusions Our results provide a systematic resource for understanding the genetic predispositions of multimorbidities and indicate that hub diseases and converged molecules and functions may be the key for treating multimorbidities. We have created an online database that facilitates researchers and physicians to browse, search, or download these multimorbidities ( https://multimorbidity.comp-sysbio.org ).

genetics & heredity
Utilization of Electronic Medical Records and Biomedical Literature to Support Rare Disease Diagnosis (Preprint)

Feichen Shen,Sijia Liu,Yanshan Wang,Andrew Wen,Liwei Wang,Hongfang Liu

DOI: https://doi.org/10.2196/preprints.11301

2018-06-15

Abstract:BACKGROUND In the United States, rare diseases are defined as those affecting fewer than 200,000 patients at any given time. Patients with rare diseases are frequently either misdiagnosed or left undiagnosed, possibly due in part to a lack of knowledge or experience with the rare disease on the part of care providers. With an exponentially growing volume of electronically accessible medical data, a large volume of information on thousands of rare diseases and their potentially associated diagnostic information is buried in electronic medical records (EMRs) and medical literature. OBJECTIVE We hypothesize that patients’ phenotypic information available within these heterogeneous resources (e.g., electronic medical records and biomedical literature) can be leveraged to accelerate disease diagnosis. In this study, we aimed to leverage information contained in heterogeneous datasets to assist rare disease diagnosis. METHODS In a previous study, we proposed utilizing a collaborative filtering recommendation system enriched with natural language processing and semantic techniques to assist rare disease diagnosis based on phenotypic characterizations derived solely from EMR data. In this study, in order to further investigate the performance of collaborative filtering on heterogeneous datasets, we studied EMR data generated at Mayo Clinic as well as published article abstracts retrieved from the Semantic MEDLINE Database. Specifically, in this study, we applied Tanimoto coefficient similarity, overlap coefficient similarity, Fager & McGowan coefficient similarity, and log likelihood ratio similarity with K nearest neighbor and threshold based patient neighbor algorithms on various combinations of datasets. RESULTS We evaluated different approaches to this problem using characterizations derived from various combinations of EMR data and literature, as well as with solely EMR data. We extracted 12.8 million EMRs from the Mayo Clinic unstructured patient cohort generated between 2010 through 2015 and retrieved all article abstracts from the semi-structured Semantic MEDLINE Database that were published through the end of 2016. We applied a collaborative filtering model and compared the performance generated by different metrics. Log likelihood ratio similarity combined with K nearest neighbor on heterogeneous datasets showed the optimal performance in patient recommendation with PRAUC 0.475 (string match), 0.511 (SNOMED match), and 0.752 (GARD match). Log likelihood ratio similarity also performed the best with mean average precision 0.465 (string match), 0.5 (SNOMED match), and 0.749 (GARD match). Performance of rare disease prediction was also demonstrated by using the optimal algorithm. Macro-average F-measure for string, SNOMED-CT, and GARD match were 0.32, 0.42, and 0.63, respectively. CONCLUSIONS This study demonstrated potential utilization of heterogeneous datasets in a collaborative filtering model to support rare disease diagnosis. In addition to phenotypic-based analysis, in the future, we plan to resolve the heterogeneity issue and reduce miscommunication between EMR and literature by mining genotypic information to establish a comprehensive disease-phenotype-gene network for rare disease diagnosis.
Mergeomics 2.0: a web server for multi-omics data integration to elucidate disease networks and predict therapeutics

Jessica Ding,Montgomery Blencowe,Thien Nghiem,Sung-min Ha,Yen-Wei Chen,Gaoyan Li,Xia Yang

DOI: https://doi.org/10.1093/nar/gkab405

IF: 14.9

2021-05-28

Nucleic Acids Research

Abstract:Abstract The Mergeomics web server is a flexible online tool for multi-omics data integration to derive biological pathways, networks, and key drivers important to disease pathogenesis and is based on the open source Mergeomics R package. The web server takes summary statistics of multi-omics disease association studies (GWAS, EWAS, TWAS, PWAS, etc.) as input and features four functions: Marker Dependency Filtering (MDF) to correct for known dependency between omics markers, Marker Set Enrichment Analysis (MSEA) to detect disease relevant biological processes, Meta-MSEA to examine the consistency of biological processes informed by various omics datasets, and Key Driver Analysis (KDA) to identify essential regulators of disease-associated pathways and networks. The web server has been extensively updated and streamlined in version 2.0 including an overhauled user interface, improved tutorials and results interpretation for each analytical step, inclusion of numerous disease GWAS, functional genomics datasets, and molecular networks to allow for comprehensive omics integrations, increased functionality to decrease user workload, and increased flexibility to cater to user-specific needs. Finally, we have incorporated our newly developed drug repositioning pipeline PharmOmics for prediction of potential drugs targeting disease processes that were identified by Mergeomics. Mergeomics is freely accessible at http://mergeomics.research.idre.ucla.edu and does not require login.

biochemistry & molecular biology
PheNominal: an EHR-integrated web application for structured deep phenotyping at the point of care

James M Havrilla,Anbumalar Singaravelu,Dennis M Driscoll,Leonard Minkovsky,Ingo Helbig,Livija Medne,Kai Wang,Ian Krantz,Bimal R Desai

DOI: https://doi.org/10.1186/s12911-022-01927-1

2022-07-28

Abstract:Background: Clinical phenotype information greatly facilitates genetic diagnostic interpretations pipelines in disease. While post-hoc extraction using natural language processing on unstructured clinical notes continues to improve, there is a need to improve point-of-care collection of patient phenotypes. Therefore, we developed "PheNominal", a point-of-care web application, embedded within Epic electronic health record (EHR) workflows, to permit capture of standardized phenotype data. Methods: Using bi-directional web services available within commercial EHRs, we developed a lightweight web application that allows users to rapidly browse and identify relevant terms from the Human Phenotype Ontology (HPO). Selected terms are saved discretely within the patient's EHR, permitting reuse both in clinical notes as well as in downstream diagnostic and research pipelines. Results: In the 16 months since implementation, PheNominal was used to capture discrete phenotype data for over 1500 individuals and 11,000 HPO terms during clinic and inpatient encounters for a genetic diagnostic consultation service within a quaternary-care pediatric academic medical center. An average of 7 HPO terms were captured per patient. Compared to a manual workflow, the average time to enter terms for a patient was reduced from 15 to 5 min per patient, and there were fewer annotation errors. Conclusions: Modern EHRs support integration of external applications using application programming interfaces. We describe a practical application of these interfaces to facilitate deep phenotype capture in a discrete, structured format within a busy clinical workflow. Future versions will include a vendor-agnostic implementation using FHIR. We describe pilot efforts to integrate structured phenotyping through controlled dictionaries into diagnostic and research pipelines, reducing manual effort for phenotype documentation and reducing errors in data entry.
Lossless integration of multiple electronic health records for identifying pleiotropy using summary statistics

Ruowang Li,Rui Duan,Xinyuan Zhang,Thomas Lumley,Sarah Pendergrass,Christopher Bauer,Hakon Hakonarson,David S. Carrell,Jordan W. Smoller,Wei-Qi Wei,Robert Carroll,Digna R. Velez Edwards,Georgia Wiesner,Patrick Sleiman,Josh C. Denny,Jonathan D. Mosley,Marylyn D. Ritchie,Yong Chen,Jason H. Moore

DOI: https://doi.org/10.1038/s41467-020-20211-2

IF: 16.6

2021-01-08

Nature Communications

Abstract:Abstract Increasingly, clinical phenotypes with matched genetic data from bio-bank linked electronic health records (EHRs) have been used for pleiotropy analyses. Thus far, pleiotropy analysis using individual-level EHR data has been limited to data from one site. However, it is desirable to integrate EHR data from multiple sites to improve the detection power and generalizability of the results. Due to privacy concerns, individual-level patients’ data are not easily shared across institutions. As a result, we introduce Sum-Share, a method designed to efficiently integrate EHR and genetic data from multiple sites to perform pleiotropy analysis. Sum-Share requires only summary-level data and one round of communication from each site, yet it produces identical test statistics compared with that of pooled individual-level data. Consequently, Sum-Share can achieve lossless integration of multiple datasets. Using real EHR data from eMERGE, Sum-Share is able to identify 1734 potential pleiotropic SNPs for five cardiovascular diseases.

multidisciplinary sciences
IMPatienT: An Integrated Web Application to Digitize, Process and Explore Multimodal PATIENt daTa

Corentin Meyer,Norma Beatriz Romero,Teresinha Evangelista,Brunot Cadot,Jocelyn Laporte,Anne Jeannin-Girardon,Pierre Collet,Ali Ayadi,Kirsley Chennen,Olivier Poch

DOI: https://doi.org/10.3233/JND-230085

Abstract:Medical acts, such as imaging, lead to the production of various medical text reports that describe the relevant findings. This induces multimodality in patient data by combining image data with free-text and consequently, multimodal data have become central to drive research and improve diagnoses. However, the exploitation of patient data is problematic as the ecosystem of analysis tools is fragmented according to the type of data (images, text, genetics), the task (processing, exploration) and domain of interest (clinical phenotype, histology). To address the challenges, we developed IMPatienT (Integrated digital Multimodal PATIENt daTa), a simple, flexible and open-source web application to digitize, process and explore multimodal patient data. IMPatienT has a modular architecture allowing to: (i) create a standard vocabulary for a domain, (ii) digitize and process free-text data, (iii) annotate images and perform image segmentation, (iv) generate a visualization dashboard and provide diagnosis decision support. To demonstrate the advantages of IMPatienT, we present a use case on a corpus of 40 simulated muscle biopsy reports of congenital myopathy patients. As IMPatienT provides users with the ability to design their own vocabulary, it can be adapted to any research domain and can be used as a patient registry for exploratory data analysis. A demo instance of the application is available at https://impatient.lbgi.fr/.
PheME: A deep ensemble framework for improving phenotype prediction from multi-modal data

Shenghan Zhang,Haoxuan Li,Ruixiang Tang,Sirui Ding,Laila Rasmy,Degui Zhi,Na Zou,Xia Hu

2023-04-27

Abstract:Detailed phenotype information is fundamental to accurate diagnosis and risk estimation of diseases. As a rich source of phenotype information, electronic health records (EHRs) promise to empower diagnostic variant interpretation. However, how to accurately and efficiently extract phenotypes from the heterogeneous EHR data remains a challenge. In this work, we present PheME, an Ensemble framework using Multi-modality data of structured EHRs and unstructured clinical notes for accurate Phenotype prediction. Firstly, we employ multiple deep neural networks to learn reliable representations from the sparse structured EHR data and redundant clinical notes. A multi-modal model then aligns multi-modal features onto the same latent space to predict phenotypes. Secondly, we leverage ensemble learning to combine outputs from single-modal models and multi-modal models to improve phenotype predictions. We choose seven diseases to evaluate the phenotyping performance of the proposed framework. Experimental results show that using multi-modal data significantly improves phenotype prediction in all diseases, the proposed ensemble learning framework can further boost the performance.

Machine Learning,Computation and Language,Multimedia,Quantitative Methods
Multimorbidity and mortality: A data science perspective

Kien Wei Siah,Chi Heem Wong,Jerry Gupta,Andrew W Lo

DOI: https://doi.org/10.1177/26335565221105431

2022-06-01

Abstract:Background: With multimorbidity becoming the norm rather than the exception, the management of multiple chronic diseases is a major challenge facing healthcare systems worldwide. Methods: Using a large, nationally representative database of electronic medical records from the United Kingdom spanning the years 2005-2016 and consisting over 4.5 million patients, we apply statistical methods and network analysis to identify comorbid pairs and triads of diseases and identify clusters of chronic conditions across different demographic groups. Unlike many previous studies, which generally adopt cross-sectional designs based on single snapshots of closed cohorts, we adopt a longitudinal approach to examine temporal changes in the patterns of multimorbidity. In addition, we perform survival analysis to examine the impact of multimorbidity on mortality. Results: The proportion of the population with multimorbidity has increased by approximately 2.5 percentage points over the last decade, with more than 17% having at least two chronic morbidities. We find that the prevalence and the severity of multimorbidity, as quantified by the number of co-occurring chronic conditions, increase progressively with age. Stratifying by socioeconomic status, we find that people living in more deprived areas are more likely to be multimorbid compared to those living in more affluent areas at all ages. The same trend holds consistently for all years in our data. In general, hypertension, diabetes, and respiratory-related diseases demonstrate high in-degree centrality and eigencentrality, while cardiac disorders show high out-degree centrality. Conclusions: We use data-driven methods to characterize multimorbidity patterns in different demographic groups and their evolution over the past decade. In addition to a number of strongly associated comorbid pairs (e.g., cardiac-vascular and cardiac-metabolic disorders), we identify three principal clusters: a respiratory cluster, a cardiovascular cluster, and a mixed cardiovascular-renal-metabolic cluster. These are supported by established pathophysiological mechanisms and shared risk factors, and largely confirm and expand on the results of existing studies in the medical literature. Our findings contribute to a more quantitative understanding of the epidemiology of multimorbidity, an important pre-requisite for developing more effective medical care and policy for multimorbid patients.
Utilization of Electronic Medical Records and Biomedical Literature to Support the Diagnosis of Rare Diseases Using Data Fusion and Collaborative Filtering Approaches

Feichen Shen,Sijia Liu,Yanshan Wang,Andrew Wen,Liwei Wang,Hongfang Liu

DOI: https://doi.org/10.2196/11301

IF: 3.2

2018-10-10

JMIR Medical Informatics

Abstract:BACKGROUND: In the United States, a rare disease is characterized as the one affecting no more than 200,000 patients at a certain period. Patients suffering from rare diseases are often either misdiagnosed or left undiagnosed, possibly due to insufficient knowledge or experience with the rare disease on the part of clinical practitioners. With an exponentially growing volume of electronically accessible medical data, a large volume of information on thousands of rare diseases and their potentially associated diagnostic information is buried in electronic medical records (EMRs) and medical literature.OBJECTIVE: This study aimed to leverage information contained in heterogeneous datasets to assist rare disease diagnosis. Phenotypic information of patients existed in EMRs and biomedical literature could be fully leveraged to speed up diagnosis of diseases.METHODS: In our previous work, we advanced the use of a collaborative filtering recommendation system to support rare disease diagnostic decision making based on phenotypes derived solely from EMR data. However, the influence of using heterogeneous data with collaborative filtering was not discussed, which is an essential problem while facing large volumes of data from various resources. In this study, to further investigate the performance of collaborative filtering on heterogeneous datasets, we studied EMR data generated at Mayo Clinic as well as published article abstracts retrieved from the Semantic MEDLINE Database. Specifically, in this study, we designed different data fusion strategies from heterogeneous resources and integrated them with the collaborative filtering model.RESULTS: We evaluated performance of the proposed system using characterizations derived from various combinations of EMR data and literature, as well as with sole EMR data. We extracted nearly 13 million EMRs from the patient cohort generated between 2010 and 2015 at Mayo Clinic and retrieved all article abstracts from the semistructured Semantic MEDLINE Database that were published till the end of 2016. We applied a collaborative filtering model and compared the performance generated by different metrics. Log likelihood ratio similarity combined with k-nearest neighbor on heterogeneous datasets showed the optimal performance in patient recommendation with area under the precision-recall curve (PRAUC) 0.475 (string match), 0.511 (systematized nomenclature of medicine [SNOMED] match), and 0.752 (Genetic and Rare Diseases Information Center [GARD] match). Log likelihood ratio similarity also performed the best with mean average precision 0.465 (string match), 0.5 (SNOMED match), and 0.749 (GARD match). Performance of rare disease prediction was also demonstrated by using the optimal algorithm. Macro-average F-measure for string, SNOMED, and GARD match were 0.32, 0.42, and 0.63, respectively.CONCLUSIONS: This study demonstrated potential utilization of heterogeneous datasets in a collaborative filtering model to support rare disease diagnosis. In addition to phenotypic-based analysis, in the future, we plan to further resolve the heterogeneity issue and reduce miscommunication between EMR and literature by mining genotypic information to establish a comprehensive disease-phenotype-gene network for rare disease diagnosis.

medical informatics
Snoring and obstructive sleep apnea: compliance with oral appliance therapy.

L. Dort,Jabeen Hussein

DOI: https://doi.org/10.2310/7070.2004.03016

2004-06-01

The Journal of Otolaryngology

Abstract:OBJECTIVE To assess the effectiveness of oral appliances in clinical practice. DESIGN Survey of 110 subjects. SETTING Hospital-based dental practice. METHODS Questionnaire. MAIN OUTCOME MEASURES Compliance and control of sleepiness and snoring. RESULTS Fifty-seven percent of respondents were compliant with therapy, reporting control of sleepiness and snoring. CONCLUSIONS More than 50% of those on oral appliance therapy reported continued use after at least 18 months.
Knowledge-Driven Online Multimodal Automated Phenotyping System

Xin Xiong,Sara Morini Sweet,Molei Liu,Chuan Hong,Clara-Lea Bonzel,Vidul Ayakulangara Panickan,Doudou Zhou,Linshanshan Wang,Lauren Costa,Yuk-Lam Ho,Alon Geva,Kenneth D. Mandl,Suchun Cheng,Zongqi Xia,Kelly Cho,J. Michael Gaziano,Katherine P. Liao,Tianxi Cai,Tianrun Cai,Xiong,X.,Sweet,S. M.,Liu,M.,Hong,C.,Bonzel,C.-L.,Ayakulangara Panickan,V.,Zhou,D.,Wang,L.,Costa,L.,Ho,Y.-L.,Geva,A.,Mandl,K. D.,Cheng,S.-C.,Xia,Z.,Cho,K.,Gaziano,J. M.,Liao,K. P.,Cai,T.,Cai,T.

DOI: https://doi.org/10.1101/2023.09.29.23296239

2023-10-03

MedRxiv

Abstract:Though electronic health record (EHR) systems are a rich repository of clinical information with large potential, the use of EHR-based phenotyping algorithms is often hindered by inaccurate diagnostic records, the presence of many irrelevant features, and the requirement for a human-labeled training set. In this paper, we describe a knowledge-driven online multimodal automated phenotyping (KOMAP) system that i) generates a list of informative features by an online narrative and codified feature search engine (ONCE) and ii) enables the training of a multimodal phenotyping algorithm based on summary data. Powered by composite knowledge from multiple EHR sources, online article corpora, and a large language model, features selected by ONCE show high concordance with the state-of-the-art AI models (GPT4 and ChatGPT) and encourage large-scale phenotyping by providing a smaller but highly relevant feature set. Validation of the KOMAP system across four healthcare centers suggests that it can generate efficient phenotyping algorithms with robust performance. Compared to other methods requiring patient-level inputs and gold-standard labels, the fully online KOMAP provides a significant opportunity to enable multi-center collaboration.

English Else

Disseminated intravascular coagulation (DIC) seriously ill patients.

Interoperability of phenome-wide multimorbidity patterns: a comparative study of two large-scale EHR systems

High-throughput multimodal automated phenotyping (MAP) with application to PheWAS

Design and Validation of a FHIR-based EHR-driven Phenotyping Toolbox

A framework for employing longitudinally collected multicenter electronic health records to stratify heterogeneous patient populations on disease history

Computable Phenotypes (Cps) For Identifying Individuals With Multi-Morbidity From Real-World Data (Rwd): A Systematic Literature Review

PheW2P2V: a phenome-wide prediction framework with weighted patient representations using electronic health records

How to build personalized multi-omics comorbidity profiles

Mergeomics: a web server for identifying pathological pathways, networks, and key regulators via multidimensional data integration

The Phenotype Execution and Modeling Architecture ( PhEMA ) – A Standards-Based Composition of Software for Phenotype Algorithm Development

A global overview of genetically interpretable multimorbidities among common diseases in the UK Biobank

Utilization of Electronic Medical Records and Biomedical Literature to Support Rare Disease Diagnosis (Preprint)

Mergeomics 2.0: a web server for multi-omics data integration to elucidate disease networks and predict therapeutics

PheNominal: an EHR-integrated web application for structured deep phenotyping at the point of care

Lossless integration of multiple electronic health records for identifying pleiotropy using summary statistics

IMPatienT: An Integrated Web Application to Digitize, Process and Explore Multimodal PATIENt daTa

PheME: A deep ensemble framework for improving phenotype prediction from multi-modal data

Multimorbidity and mortality: A data science perspective

Utilization of Electronic Medical Records and Biomedical Literature to Support the Diagnosis of Rare Diseases Using Data Fusion and Collaborative Filtering Approaches

Snoring and obstructive sleep apnea: compliance with oral appliance therapy.

Knowledge-Driven Online Multimodal Automated Phenotyping System